Skip to main content

Advertisement

Log in

Post-transfusion hepatitis and its association with pooled clotting factors

  • Original Articles
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

A prospective study of post-transfusion hepatitis was conducted in 97 adult patients undergoing open heart surgery. Twelve patients developed presumed non-A, non-B hepatitis (five of these were hospitalized and three were jaundiced), and all 12 had received clotting factors from pooled plasma (fibrinogen, factor VIII, factor IX complex) from different manufacturers. Of the remaining 85 patients none received these high risk plasma derivatives and none developed hepatitis. Multiple peak ALT elevation seems to be an indication of development of chronic non-A, non-B hepatitis. In addition to the 12 cases of presumed non-A, non-B hepatitis, nine cases of serological changes related to hepatitis B virus were observed as follows: six early booster reactions of anti-HBs, but not anti-HBc, in anti-HBs and anti-HBc positive persons; one late immunization-like response for anti-HBs and two serological hepatitis B infections without transaminase elevation. Five of the nine cases were also associated with the administration of pooled clotting factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Prince, A. M., Brotman, B., Grady, G. F., Kuhns, W. J., Hazzi, C., Levine, R. W., Millian, S. J.: Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet 1974, ii: 241–246.

    Google Scholar 

  2. Alter, H. J., Purcell, R. H., Holland, P. V., Feinstone, S. M., Morrow, A. G., Moritsugu, Y.: Clinical and serological analysis of transfusion-associated hepatitis. Lancet 1975, ii: 838–841.

    Google Scholar 

  3. Knodell, R. G., Conrad, M. E., Ginsberg, A. L., Bell, C. J., Flannery, E. P.: Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1976, i: 557–561.

    Google Scholar 

  4. Seeff, L. B., Zimmerman, H. J., Wright, E. C., Finkelstein, J. D., Garcia-Pont, P., Greenlee, H. B., Dietz, A. A., Leevy, C. M., Tamburro, C. H., Schiff, E. R., Schimmel, E. M., Zemel, R., Zimmon, D. S., McCollum, R. W.: A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroenterology 1977, 72: 111–121.

    PubMed  Google Scholar 

  5. Berman, M., Alter, H. J., Ishak, K. G., Purcell, R. H., Jones, E. A.: The chronic sequelae of non-A, non-B hepatitis. Annales of Internal Medicine 1979, 91: 1–6.

    Google Scholar 

  6. Tremolada, F., Realdi, G., Noventa, F., Alberti, A., Pornada, E., Valfre, C., Gallucci, V.: Post-transfusion hepatitis in Italy. Lancet 1982, i: 853–854.

    Google Scholar 

  7. Cossart, Y. E., Kirsch, S., Ismay, S. L.: Post-transfusion hepatitis in Australia. Lancet 1982, i: 208–213.

    Google Scholar 

  8. Ohlmeier, H., Dahmen, E., Hoppe, I.: Hepatitis-risiko von humanen Gerinnungspräparaten aus gepoolten Plasmen. Deutsche Medizinische Wochenschrift 1978, 103: 1700–1703.

    PubMed  Google Scholar 

  9. Sugg, U., Schnaidt, M., Schneider, W., Lissner, R.: Clotting factors and non-A, non-B hepatitis. New England Journal of Medicine 1980, 303: 943.

    Google Scholar 

  10. Aach, R. D., Szmuness, W., Mosley, J. W., Hollinger, F. B., Kahn, R. A., Stevens, C. E., Edwards, V. M., Werch, J.: Serum alanine amino-transferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study. New England Journal of Medicine 1981, 304: 989–994.

    PubMed  Google Scholar 

  11. Prince, A. M., Stephan, W., Brotman, B.: β-propiolactone ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivates. Reviews of Infectious Diseases 1983 (in press).

  12. Roggendorf, M., Deinhardt, F., Frösner, G. G., Scheid, R., Bayerl, B., Zachoval, R.: Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection. Journal of Clinical Microbiology 1981, 13: 618–626.

    PubMed  Google Scholar 

  13. Hoofnagle, J. H., Seeff, L. B., Bales, Z. B., Gerety, R. J., Tabor, E.: Serologic responses in HB. In: Vyas, G. N., Cohen, S. N., Schmid, R. (ed.): Viral hepatitis. Franklin Institute Press, Philadelphia, 1978, p. 219–242.

    Google Scholar 

  14. Craske, J., Spooner, R. J. D., Vandervelde, E. M.: Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis. Lancet 1978, ii: 1051–1052.

    Google Scholar 

  15. Craske, J., Dilling, N., Stern, D.: An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate. Lancet 1975, ii: 221–223.

    Google Scholar 

  16. Hruby, M. A., Schauf, V.: Transfusion-related short-incubation hepatitis in hemophilic patients. Journal of the American Medical Association 1978, 240: 1355–1357.

    PubMed  Google Scholar 

  17. Wyke, R. J., Tsiquaye, K. N., Thornton, A., White, Y., Portman, B., Das, P. K., Zuckerman, A. J., Williams, R.: Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet 1979, i: 520–524.

    Google Scholar 

  18. Kim, H. C., Saidi, P., Ackley, A. M., Bringelsen, K. A., Gocke, D. J.: Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Gastroenterology 1980, 79: 1159–1164.

    PubMed  Google Scholar 

  19. Yoshizawa, H., Akahane, Y., Itoh, Y., Iwakiri, S., Kitajima, K., Morita, M., Tanaka, A., Nojiri, T., Shimizu, M., Miyakawa, Y., Mayum, M.: Viruslike particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A, non-B hepatitis in humans and chimpanzees. Gastroenterology 1980, 79: 512–520.

    PubMed  Google Scholar 

  20. Tateda, A., Kikuchi, K., Numazaki, Y., Shirachi, R., Ishida, N.: Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologie studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. Journal of Infectious Diseases 1979, 139: 511–518.

    PubMed  Google Scholar 

  21. Hoofnagle, J. H., Seeff, L. B., Bales, Z. B., Zimmerman, H. J.: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. New England Journal of Medicine 1978, 298: 1379–1383.

    PubMed  Google Scholar 

  22. Katchaki, J. N., Siem, T. H., Brouwer, R.: Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donors. Journal of Clinical Pathology 1978, 31: 837–839.

    PubMed  Google Scholar 

  23. Sugg, U., Erhardt, S., Schneider, W.: Chronic “low-level” hepatitis B virus carrier with probable infectivity. Lancet 1982, i: 446–447.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugg, U., Frösner, G.G., Lissner, R. et al. Post-transfusion hepatitis and its association with pooled clotting factors. Eur. J, Clin. Microbiol. 2, 135–140 (1983). https://doi.org/10.1007/BF02001579

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02001579

Keywords

Navigation